M
NeuroBo Pharmaceuticals (MTVA)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About NeuroBo Pharmaceuticals (MTVA)
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused primarily on therapies for cardiometabolic diseases. Its therapeutics programs include DA-1241 and DA-1726. DA-1241 is a novel G-Protein-Coupled Receptor ... Read more
- USD0.97
- USD1.10
- USD0.97
- USD3.50
- 62.50%
- --
- 435.22k
- 3.35M
- 25M
- 0.56
- -68.10%
Stock News
3 hours ago
Spirit Airlines to furlough 1,800 flight attendants to cut costs in bankruptcy
CNBC
3 hours ago
Palantir has ‘main-character energy.’ Here’s how that can help its stock power higher.
MarketWatch
3 hours ago
Jim Cramer looks at Apple's soaring stock as T-Mobile sees record iPhone sales
CNBC
4 hours ago
Incomes fell in 7 major US cities in 2024—where Americans earned less
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
